Analysis of Effectiveness and Safety of Teclistamab in Relapsed and Refractory Multiple Myeloma Patients
- Conditions
- Multiple Myeloma
- First Posted Date
- 2023-10-02
- Last Posted Date
- 2023-10-02
- Lead Sponsor
- Intergroupe Francophone du Myelome
- Target Recruit Count
- 200
- Registration Number
- NCT06062537
- Locations
- 🇫🇷
Hopital de la cote Basque, Bayonne, France
🇫🇷CHU Bordeaux, Bordeaux, France
🇫🇷CHU CAEN, Caen, France
Diagnostic Performance of Spot Urine Sample for the Monoclonal Components Detection in Patients With Multiple Myeloma
- Conditions
- Multiple Myeloma
- Interventions
- Diagnostic Test: Detection of monoclonal component
- First Posted Date
- 2022-01-26
- Last Posted Date
- 2024-03-18
- Lead Sponsor
- Intergroupe Francophone du Myelome
- Target Recruit Count
- 300
- Registration Number
- NCT05208086
- Locations
- 🇫🇷
Centre Hospitalier William Morey, Chalon Sur Saone, France
🇫🇷Centre Hospitalier Métropole de Savoie, Chambéry, France
🇫🇷Ch Le Mans, Le Mans, France
Isatuximab Plus Pomalidomide and Dexamethasone Association for Patients With AL Amyloidosis Not in VGPR or Better After Any Previous Therapy
- First Posted Date
- 2021-10-04
- Last Posted Date
- 2024-03-06
- Lead Sponsor
- Intergroupe Francophone du Myelome
- Target Recruit Count
- 46
- Registration Number
- NCT05066607
- Locations
- 🇫🇷
CHRU - Hôpital du Bocage, Angers, France
🇫🇷CHU Caen - Côte de Nacre, Caen, France
🇫🇷Groupe Hospitalier Mutualiste de Grenoble, Grenoble, France
MInimal Residual Disease Adapted Strategy
- First Posted Date
- 2021-06-22
- Last Posted Date
- 2024-11-07
- Lead Sponsor
- Intergroupe Francophone du Myelome
- Target Recruit Count
- 791
- Registration Number
- NCT04934475
- Locations
- 🇫🇷
Hôpitaux Universitaires de Strasbourg - Hôpital de Hautepierre, Strasbourg, France
🇷🇪CHU de La Réunion site Sud, Saint-Pierre, Réunion
🇫🇷CHU Amiens Sud, AMIENS Cedex 1, France
Analysis of the Immune Parameters of COVID-19 Infection in Patients With Multiple Myeloma
- Conditions
- Covid19Multiple Myeloma
- Interventions
- Other: blood sample analyses
- First Posted Date
- 2021-03-18
- Last Posted Date
- 2023-10-19
- Lead Sponsor
- Intergroupe Francophone du Myelome
- Target Recruit Count
- 139
- Registration Number
- NCT04805203
- Locations
- 🇫🇷
ICANS, Strasbourg, France
🇫🇷Clinique du Parc, Castelnau-le-Lez, France
🇫🇷CHU Henri Mondor, Créteil, France
Evaluation of the Impact of the Update SMM Criteria on the Natural History of SMM to Establish New Recommendations.
- Conditions
- Smoldering Multiple Myeloma
- Interventions
- Procedure: Myelogram
- First Posted Date
- 2019-10-30
- Last Posted Date
- 2024-03-06
- Lead Sponsor
- Intergroupe Francophone du Myelome
- Target Recruit Count
- 395
- Registration Number
- NCT04144387
- Locations
- 🇧🇪
CHU UCL Namur ASBL Site Godinne, Yvoir, Belgium
🇧🇪Cliniques Universitaires Saint-Luc, Bruxelles, Belgium
🇫🇷Centre hospitalier de la Côte Basque, Bayonne, France
IPD in RRMM Characterized With Genomic Abnormalities of Adverse Prognostic
- Conditions
- Multiple MyelomaRelapsed and Refractory Multiple MyelomaGenetic Condition
- Interventions
- Drug: Ixazomib/Pomalidomide/Dexamethasone
- First Posted Date
- 2018-09-25
- Last Posted Date
- 2023-06-05
- Lead Sponsor
- Intergroupe Francophone du Myelome
- Target Recruit Count
- 26
- Registration Number
- NCT03683277
- Locations
- 🇫🇷
Centre hospitalier départemental de Vendée, La Roche-sur-Yon, France
🇫🇷CH Avignon - Centre Hospitalier H.Duffaut, Avignon, France
🇫🇷CHU de Dijon, Dijon, France
Assessment of Mobilization Cost for Multiple Myeloma Using 2 Different Mobilization Strategies
- Conditions
- Multiple MyelomaBlood Stem Cell Transplant Failure
- First Posted Date
- 2016-12-20
- Last Posted Date
- 2016-12-20
- Lead Sponsor
- Intergroupe Francophone du Myelome
- Target Recruit Count
- 112
- Registration Number
- NCT02997813
- Locations
- 🇫🇷
Hôpital Saint-Antoine, Paris, France
🇫🇷Institut Curie Centre de Lutte Contre le Cancer (CLCC), Paris, France
🇫🇷Hôpital Robert Debré Hématologie, Reims, France
A Study to Evaluate Daratumumab in Transplant Eligible Participants With Previously Untreated Multiple Myeloma
- Conditions
- Multiple Myeloma
- Interventions
- First Posted Date
- 2015-09-04
- Last Posted Date
- 2020-12-07
- Lead Sponsor
- Intergroupe Francophone du Myelome
- Target Recruit Count
- 1085
- Registration Number
- NCT02541383
- Locations
- 🇫🇷
Centre Léon Bérard, Lyon, France
🇧🇪AZ St Jan Brugge Oostende AV, Brugge, Belgium
🇧🇪UZ Brussel, Bruxelles, Belgium
Study of Bendamustine, Velcade and Dexamethasone in the Treatment of Elderly Patients With Multiple Myeloma
- Conditions
- Multiple Myeloma
- Interventions
- First Posted Date
- 2010-01-11
- Last Posted Date
- 2020-12-07
- Lead Sponsor
- Intergroupe Francophone du Myelome
- Target Recruit Count
- 75
- Registration Number
- NCT01045681
- Locations
- 🇫🇷
Hôpital Avicenne, Bobigny, France
🇫🇷CHRU Hôpital Sud, Amiens, France
🇫🇷CHRU, Hôpital du Bocage, Angers, France